| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/07/1998 | EP0815227A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6, NUCLEIC ACIDS ENCODING SAME AND USES THEREOF |
| 01/07/1998 | EP0815222A1 Sperm factor |
| 01/07/1998 | EP0815220A1 Human amine transporter |
| 01/07/1998 | EP0815219A1 Human b-cell translocation genes-2 and 3 |
| 01/07/1998 | EP0815216A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof |
| 01/07/1998 | EP0815213A1 An immortalized mammal hybridoma fusion partner |
| 01/07/1998 | EP0815202A1 Human tissue inhibitor of metalloproteinase-4 |
| 01/07/1998 | EP0815142A1 Antigen composition against mycoplasma |
| 01/07/1998 | EP0815141A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 01/07/1998 | EP0815140A1 Production in yeasts of stable antibody fragments |
| 01/07/1998 | EP0815137A1 Human g-protein chemokine receptor hdgnr10 |
| 01/07/1998 | EP0815132A1 Leptospiral outer membrane proteins |
| 01/07/1998 | EP0815129A1 Ingap protein involved in pancreatic islet neogenesis |
| 01/07/1998 | EP0815125A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES |
| 01/07/1998 | EP0815116A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0814837A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/07/1998 | EP0814834A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 01/07/1998 | EP0814827A1 Vascular endothelial growth factor-b |
| 01/07/1998 | EP0814826A1 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 01/07/1998 | EP0814661A1 UBIQUITIN CONJUGATING ENZYMES 7, 8 and 9 |
| 01/07/1998 | EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY |
| 01/07/1998 | EP0682529B1 Antibody for the treatment of insulin dependent diabetes |
| 01/07/1998 | EP0552142B1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 01/07/1998 | EP0486572B1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 01/07/1998 | EP0463110B1 Monoclonal antibodies for metallic cations |
| 01/07/1998 | EP0447424B1 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 01/07/1998 | CN1169754A Human interleudin-1 receptor accessory Protein |
| 01/07/1998 | CN1169735A CD 23 binding agent |
| 01/07/1998 | CN1169729A Modulators functions of FAS/APOL receptors |
| 01/06/1998 | US5705732 Protection against hyperacute rejection |
| 01/06/1998 | US5705625 Genetic engineering; medical diagnosis |
| 01/06/1998 | US5705615 Antibodies specific for HTm4 |
| 01/06/1998 | US5705614 Methods of producing antigen forks |
| 01/06/1998 | US5705610 Suspension solution, coupling, withdrawal and mixing |
| 01/06/1998 | US5705608 Polypeptides with dna sequence codes |
| 01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
| 01/06/1998 | US5705377 Tyrosine kinase |
| 01/06/1998 | US5705364 Mammalian cell culture process |
| 01/06/1998 | US5705363 Recombinant production of human interferon τ polypeptides and nucleic acids |
| 01/06/1998 | US5705359 Expression of heterologous proteins in drosophila cells |
| 01/06/1998 | US5705341 MDC proteins and DNAs encoding the same |
| 01/06/1998 | US5705334 Uses for DNA structure-specific recognition protein |
| 01/06/1998 | US5705331 HIV nucleocapsid protein capture assay and method of use |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705157 Methods of treating cancerous cells with anti-receptor antibodies |
| 01/06/1998 | US5705154 Humanized monoclonal antibodies against human interleukin-4 |
| 01/06/1998 | US5705150 Antigen specific plasmacytomas and antibodies derived therefrom |
| 01/06/1998 | US5705149 Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors |
| 01/02/1998 | DE19650758C1 PKD1 protein fragments, DNA and antibodies |
| 01/02/1998 | DE19627352A1 Vakzine gegen Kohlenhydrat-Antigene Vaccine against carbohydrate antigens |
| 12/31/1997 | WO1997049994A1 Method and kit for the diagnosis of troponin i |
| 12/31/1997 | WO1997049832A2 Method of identifying cytochrome p450 |
| 12/31/1997 | WO1997049819A1 Novel amino-terminal deblocking enzyme |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049815A1 Retinoid metabolizing protein |
| 12/31/1997 | WO1997049809A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 12/31/1997 | WO1997049805A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 12/31/1997 | WO1997049732A1 IgG IMMUNOGLOBULINS AND F(ab')2 FRAGMENTS THEREOF, SPECIFIC FOR DRUGS AND METABOLITES THEREOF, AND THEIR USE FOR DETOXIFICATION PURPOSES |
| 12/31/1997 | WO1997049727A1 Aatt promoter element and transcription factor |
| 12/31/1997 | WO1997049720A1 Recombinant fusion protein comprising pdc-e2, bcoadc-e2, and ogdc-e2 and uses thereof |
| 12/31/1997 | WO1997049429A1 Genetically engineered immunoglobulins with specificity for glycated albumin |
| 12/31/1997 | WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 12/31/1997 | WO1997049427A1 Drugs for ameliorating renal disorders |
| 12/31/1997 | WO1997049426A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient |
| 12/31/1997 | WO1997049424A1 Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same |
| 12/31/1997 | WO1997044454A3 Human phospholipase inhibitor |
| 12/31/1997 | WO1997044000A3 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 12/31/1997 | WO1997030159A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 12/31/1997 | CA2261029A1 Aatt promoter element and transcription factor |
| 12/31/1997 | CA2257180A1 Method of identifying cytochrome p450 |
| 12/31/1997 | CA2256684A1 Recombinant fusion protein comprising pdc-e2, bcoadc-e2, and ogdc-e2 and uses thereof |
| 12/31/1997 | CA2254782A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient |
| 12/30/1997 | US5703213 Monoclonal antibodies which recognize an adenocarcinoma cell antigen |
| 12/30/1997 | US5703209 Purified and isolated polypeptide encoded by nucleic acid sequence of nucleic acid molecule which is fragment of gene encoding amyloid precursor protein isoform |
| 12/30/1997 | US5703207 Protein active in humoral hypercalcemia of malignancy-PTHrP |
| 12/30/1997 | US5703206 Macrophage inflammatory protein 2 (MIP-2) |
| 12/30/1997 | US5703057 Expression library immunization |
| 12/30/1997 | US5703048 Hepatocyte growth factor |
| 12/30/1997 | US5703046 Treatment method using recombinantly produced human membrane cofactor protein (MCP) |
| 12/30/1997 | US5702946 Interleukins |
| 12/30/1997 | US5702937 Method for potentiating tissue plasminogen activator with β-lactoglobulin |
| 12/30/1997 | US5702936 Polypeptides |
| 12/30/1997 | US5702920 Polypeptides |
| 12/30/1997 | US5702917 Polynucleotides encoding human ICAM-4 |
| 12/30/1997 | US5702910 Using two kinds of monoclonal antibodies; complexing |
| 12/30/1997 | US5702909 Methods of detecting collagen type II degradation in vivo |
| 12/30/1997 | US5702907 Nucleotide sequence |
| 12/30/1997 | US5702906 Preferentially binds neurotropic factor-4 but does not bind nerve growth factor, brain-derived neurotropic factor, or neuronal factor |
| 12/30/1997 | US5702905 Specificity, sensitivity; diagnosis of cardiac muscle damage |
| 12/30/1997 | US5702904 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 12/30/1997 | US5702903 Detecting gene that has been amplified or detecting increased expression of gene products |
| 12/30/1997 | US5702892 Phage-display of immunoglobulin heavy chain libraries |
| 12/30/1997 | US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 12/30/1997 | US5702708 Salmonicida iron regulated protein and lipopolysaccharide vaccine |
| 12/30/1997 | US5702707 A polypeptide including amino acid sequence extending from position 92 to 109 of p17 gag protein of hiv-1, total number of amino acid does not exceed about 40; basis for vaccine |
| 12/30/1997 | US5702705 Antibody methods for the treatment of a hormone-mediated disease |
| 12/30/1997 | US5702704 Antibodies to in vivo advanced glycosylation endproducts |
| 12/30/1997 | CA1339607C Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |